Muscle-invasive bladder cancer (MIBC) remains a deadly disease, despite aggressive surgical and systemic chemotherapeutic treatments. New treatment modalities are needed. A novel intravesicle drug delivery device for neoadjuvant treatment of MIBC has been developed, and preliminary results on the efficacy and safety of this system are available.

中文翻译：

---

用于 MIBC 新辅助治疗的新型膀胱内吉西他滨输送系统 (TAR-200)：背景就是一切

尽管进行了积极的手术和全身化疗治疗，但肌肉浸润性膀胱癌 (MIBC) 仍然是一种致命疾病。需要新的治疗方式。研制了一种新型的用于 MIBC 新辅助治疗的囊内给药装置，并对该系统的有效性和安全性进行了初步研究。